Phone
Address Talkabouturology, Nizhny Novgorod, Russia
Skype ukitcom
Email Talkabouturology@list.ru
                                    Talk about urology
Back to the list

Adjuvant Immunotherapy? Nivolumab may be the first immune checkpoint inhibitor indicated for adjuvant use in patients with urothelial cancer, a matter that the FDA is already prioritizing. Detailed data are presented in the current issue of the journal "Oncourology".

 https://roou.ru/blog/2021/05/12/adyuvantnaya-immunoterapiya/?fbclid=IwAR1Pc-1JOVd0ovdjT06V8AWkocNYFYokgQC37Gc6CUHME4B0GMHwQbvo6lM